South Florida
Integrated Kidney Partners II LLC
Primary Contact
Ryan Pardo
Ryan.Pardo@usrenalcare.com
KCE Participants
Dialysis Facilities
| New Smyrna Beach Artificial Kidney, LC | 70620 Partners, LLC |
| USRC Uptown Naples LLC | 70820 Ventures, LLC |
| USRC Mustang Dialysis, LLC | 70920 Ventures, LLC |
| 5072020, LLC | 71020 Ventures, LLC |
| 70720 Partners, LLC | 71120 Ventures, LLC |
Practices
Associates in Nephrology Butcher & Devacaanthan MD PA
| Aastha Parsa | Neetu Malhotra |
| Basudev Pudasaini | Parameswari Somavaram |
| Bishal Rawal | Peggy Depalma |
| Evan Gross | Robert Payne |
| John Conrey | Sourab Dhungel |
| Katie Anderson | Syeda Khan |
| Magdala Guerrier | Tamim Ghith |
| Mary Mouracade |
Mogilishetty PLLC
| Beenu Singh | Meloney Oliveira |
| Gautham Mogilishetty | Natasha Dave |
| Ibrahim Khambati | Kathlin Chou |
Independent Practitioners
| Christopher Mai |
Preferred Providers
| Practice | Provider Name |
|---|---|
| Personal Recovery Network LLC | |
| Rocky Mountain Kidney Care LLC | |
| Mogilishetty PLLC | Natalia Mysh |
Joint Ventures
There are no joint ventures between or among the KCE and any of its KCE Participant and Preferred Providers.
Administrative Lead
| Name | Employer |
|---|---|
| Alan St. Pierre | KidneyLink |
Clinical Lead
| Name | Employer |
|---|---|
| Bishal Rawal | Associates in Nephrology |
KCE Governing Body Members
| Member | Title | Organization |
|---|---|---|
| Alan St. Pierre | SVP, VBC (KCE Manager) | KidneyLink |
| Bishal Rawal | M.D. (KCE Medical Director) | Associates in Nephrology |
| Gautham Mogilishetty | M.D. (Transplant Provider) | Mogilishetty PLLC |
| Basudev Pudasaini | M.D. | Associates in Nephrology |
| Lori Hartwell | Founder (Consumer Advocate) | Renal Support Network |
| Stephen Busenlehner | Sr. Dir., VBC Market Ops. | KidneyLink |
| Unicka Ssempira | U.S. Renal Care |
Shared Savings and Shared Losses Information
a. Gross Savings/Losses BEFORE CMS withholds
PY2022: $1,585,735
PY2023: ($1,848,002)
PY2024: $3,049,074
b. The amount of Shared Savings or Shared Losses, net of CMS Withholds and Aggregation;
PY2022: ($74,792)
PY2023: ($1,064,429)
PY2024: $1,486,929
c. The proportion of Shared Savings invested in infrastructure, redesigned care processes, and other resources necessary to improve outcomes and reduce Medicare costs for Beneficiaries; and
PY2022: N/A
PY2023: N/A
PY2024: 99%
d. The proportion of Shared Savings distributed to KCE Participants and Preferred Providers
PY2022: N/A
PY2023: N/A
PY2024: 1%
Total Quality Score (TQS)
Total Quality Score (TQS) results out of 100%, based on KCE quality measure performance during the period
Performance Year 2022 TQS: 25%
Performance Year 2023 TQS: 75%
Performance Year 2024 TQS: 100%
Earned High Performance Pool designation
Total Program Income to Participants
PY2022: $917,685
PY2023: $926,085
PY2024: $1,195,643